Setback for LHON Treatment in the US: IMP Supports Urgent Patient Need
Setback for LHON Treatment in the US: IMP Supports Urgent Patient Need International Mito Patients (IMP), the global federation representing patient […]
mitochondrial diseases
EMA grants positive CHMP opinion for KYGEVVI® for Treatment of TK2d
EMA grants positive CHMP opinion for Kygevvi® for Treatment of TK2d International Mito Patients (IMP) and the global mitochondrial disease community
Amplifying Our Collective Voice: IMP at National and International Events
Amplifying Our Collective Voice: IMP at National and International Events As members of IMP, we are part of a global
Mitochondrial Awareness Week 2025: 1.5million reached!!
Mitochondrial Awareness Week 2025: 1.5million reached!! This September, our community united for World Mitochondrial Disease Week, a celebration of green lights,
First patient with rare muscle disease treated with own stem cells
First patient with rare muscle disease treated with own stem cells 9 November 2025 Maastricht UMC+ has, for the first
IMP Welcomes FDA Approval of First-Ever Treatment for TK2d
IMP Welcomes FDA Approval of First-Ever Treatment for TK2d International Mito Patient (IMP) is delighted to welcome yesterday’s approval by
Watch our Webinar: The power of nutrition and mitochondrial diseases
Watch our Webinar: The power of nutrition and mitochondrial diseases As part of LHON Awareness Day, we hosted a powerful
Scientists provide first evidence that the drug sildenafil may benefit patients with Leigh syndrome, and particularly those carrying mutations in the mitochondrial gene MT-ATP6.